Enanta Pharmaceuticals (ENTA) EBT Margin Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,857.00 |
| Dec 31, 2025 | -2,739.00 |
| Sep 30, 2025 | -4,457.00 |
| Jun 30, 2025 | 1,524.00 |
| Mar 31, 2025 | -12,452.00 |
| Dec 31, 2024 | -16,232.00 |
| Sep 30, 2024 | -21,677.00 |
| Jun 30, 2024 | -14,219.00 |
| Mar 31, 2024 | -18,720.00 |
| Dec 31, 2023 | -23,157.00 |
| Sep 30, 2023 | -20,930.00 |
| Jun 30, 2023 | -22,631.00 |
| Mar 31, 2023 | -25,207.00 |
| Dec 31, 2022 | -16,329.00 |
| Sep 30, 2022 | -20,199.00 |
| Jun 30, 2022 | 177.00 |
| Mar 31, 2022 | -7,951.00 |
| Dec 31, 2021 | -4,644.00 |
| Sep 30, 2021 | -12,118.00 |
| Jun 30, 2021 | -14,990.00 |
| Mar 31, 2021 | -14,410.00 |
| Dec 31, 2020 | -11,076.00 |
| Sep 30, 2020 | -10,787.00 |
| Jun 30, 2020 | -13,192.00 |
| Mar 31, 2020 | -12,095.00 |
| Dec 31, 2019 | -6,255.00 |
| Sep 30, 2019 | 20,999.00 |
| Jun 30, 2019 | -6,916.00 |
| Mar 31, 2019 | 24,325.00 |
| Dec 31, 2018 | 64,390.00 |
| Sep 30, 2018 | 38,275.00 |
| Jun 30, 2018 | 29,281.00 |
| Mar 31, 2018 | 37,205.00 |
| Dec 31, 2017 | -3,850.00 |
| Sep 30, 2017 | 29,062.00 |
| Jun 30, 2017 | -2,991.00 |
| Mar 31, 2017 | -18,779.00 |